Betta Pharmaceuticals announced that the shareholder Hangzhou Terry Xichuang Enterprise Management Partnership's holdings reduction plan has expired. From May 8 to August 7, 2026, it reduced its holdings of 495,900 shares through centralized bidding transactions, accounting for 0.1171% of the total share capital, and reduced its holdings at an average price of 69.99 yuan/share. After the holdings were reduced, Tracy's shares fell to 28,301,161 shares, accounting for 6.6853% of the total share capital. This holdings reduction complies with relevant regulations, is consistent with the pre-disclosure plan, and does not violate promises.

Betta Pharmaceuticals announced that the shareholder Hangzhou Terry Xichuang Enterprise Management Partnership's holdings reduction plan has expired. From May 8 to August 7, 2026, it reduced its holdings of 495,900 shares through centralized bidding transactions, accounting for 0.1171% of the total share capital, and reduced its holdings at an average price of 69.99 yuan/share. After the holdings were reduced, Tracy's shares fell to 28,301,161 shares, accounting for 6.6853% of the total share capital. This holdings reduction complies with relevant regulations, is consistent with the pre-disclosure plan, and does not violate promises.